№ lp_1_2_30360
File format: docx
Character count: 11147
File size: 56 KB
The document provides detailed safety and handling information for human red cell reagents used in in-vitro diagnostics, outlining composition, hazards, first aid measures, storage conditions, and disposal guidelines.
Year:
2023
Region / city:
United Kingdom, Liverpool
Subject:
Safety Data Sheet for human red cell reagents
Document type:
Safety Data Sheet
Organization:
NHSBT Reagents
Author:
NHSBT Reagents
Target audience:
Healthcare professionals, laboratory technicians
Period of validity:
Not specified
Approval date:
Not specified
Date of changes:
Not specified
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2023
Region / City:
Sydney, Australia
Topic:
Pharmaceutical Sciences, Aerosol Drug Delivery, Inhaler Technology
Document Type:
Research Article
Organization / Institution:
Woolcock Institute of Medical Research, Macquarie University, Monash University, Kindeva Drug Delivery
Author:
Hui Xin Ong, Nirmal Marasini, Lingzhe Rao, Daniel Duke, Damon Honnery, Stephen W. Stein, Benjamin Myatt, Phil Cocks, Paul Young
Target Audience:
Researchers, Pharmaceutical Scientists, Engineers in Drug Delivery
Effective Period:
Not specified
Approval Date:
Not specified
Modification Date:
Not specified
Year:
2023
Region / City:
Rivers State, Nigeria
Topic:
Antioxidant, Anti-inflammatory, Molecular Docking, Hepatoprotective
Document Type:
Research Article
Institution:
Rivers State University
Author:
Not specified
Target Audience:
Researchers, Scholars, Pharmacologists
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Revisions:
Not specified
Procedure ID:
PSAv1.0
Version number:
1.0
Release date:
20 March 2017
Developed by:
Benoit Witkowski & Didier Ménard
Institution:
Unité d’Epidémiologie Moléculaire du Paludisme, Institut Pasteur du Cambodge
Location:
Phnom Penh, Cambodia
Document type:
Laboratory procedure
Purpose:
Evaluation of Plasmodium falciparum susceptibility to piperaquine
Assay types:
In-vitro Piperaquine Survival Assay (PSA); Ex-vivo Piperaquine Survival Assay
Target organism:
Plasmodium falciparum
Drug tested:
Piperaquine (PPQ)
Drug concentration:
200 nM
Exposure duration:
48 hours
Assessment time point:
72 hours after drug exposure
Intended users:
Appropriately-equipped laboratories performing in-vitro and ex-vivo drug susceptibility testing
Quality requirements:
Training required; participation in QA/QC proficiency scheme recommended
Referenced study:
Duru et al. 2015
Contact information:
[email protected]
Year:
2023
Country:
Italy
Ministry:
Ministry of Health (Ministero della Salute)
Department:
Direzione Generale dei Dispositivi Medici e del Servizio Farmaceutico, Ufficio 4
Document Type:
Instruction/Guideline
Legal Reference:
Ministerial Decree 23 December 2013, Legislative Decree no. 332 of 8 September 2000, Regulation (EU) 2017/746
Target Audience:
Delegating and authorised companies registering in-vitro diagnostic devices
Required Attachments:
Proof of identity of legal representatives
Submission Method:
PDF via email to [email protected]
Data Entry:
Appointed responsible person for entering and updating data in “Repertorio”
Year:
2015
Region / City:
N/A
Subject:
Blood grouping reagents, quality control, serology testing
Document Type:
Procedure manual
Organization / Institution:
N/A
Author:
N/A
Target Audience:
Laboratory technicians, quality control personnel
Period of Validity:
N/A
Approval Date:
N/A
Revision Date:
September 1, 2015
Year:
2026
Region / City:
Durban, South Africa
Field:
Peptide Chemistry
Document Type:
Review Article
Institution:
University of KwaZulu-Natal
Authors:
Srinivasa Rao Manne, Beatriz G. de la Torre, Ayman El-Faham, Fernando Albericio
Target Audience:
Researchers in peptide synthesis and organic chemistry
Period of Validity:
Not specified
Date of Approval:
Not specified
Date of Changes:
Not specified
Year:
2018
Region/City:
Amarillo, TX, United States
Subject:
Procurement of Immunohistochemistry Reagents and Supplies
Document Type:
Government Contract Solicitation and Award
Issuing Agency:
Department of Veterans Affairs, Contracting Section
Contractor:
Roche (Ventana Industries, Inc.)
Target Audience:
Vendors capable of supplying proprietary reagents for Ventana Benchmark instrumentation
Effective Period:
Upon award, continuing as required for contract fulfillment
Award/Effective Date:
2018-10-09
Solicitation Number:
436C25719Q0001
Delivery Location:
Molecular Laboratory, Pathology & Laboratory Medicine Service, Audie L. Murphy VA Hospital
Payment Terms:
Net 30, electronic submission via Tungsten Network
NAICS:
325412
Contract Type:
Firm-fixed-price commercial item contract
Method of Solicitation:
RFQ/IFB/RFP
Year:
2026
Region / Institution:
Tongji University, China
Type of Document:
Laboratory resource table
Organism:
Mouse, Rat
Strains / Modifications:
USP25 knockout, USP25 variants
Materials:
Antibodies, DNA/cDNA clones, Plasmids
Source / Vendor:
Abcam, Santa Cruz Biotechnology, Proteintech, Cell Signaling Technology, MGI, RGD, Taogene, Shanghai Genechem Co., Ltd.
Applications:
Western blot (WB), Immunoprecipitation (IP), PCR primers
Persistent IDs / URLs:
Provided for all reagents and clones
Parent Animals:
Male and female USP25-KO mice
Target Antigens:
MYHC, TGF-β, COL-1, USP25, ANP, Flag, HA, GAPDH, Bcl-2, Bax, Cleave-Caspase-3, P38, p-P38, JNK, p-JNK, ERK, p-ERK, P65, p-P65, AKT, p-AKT, TAK1, p-TAK1, TBK1, P62, LC3B
Primer Sequences:
Provided for multiple mouse and rat genes
Plasmid Details:
USP25 constructs with various mutations or deletions, with URLs to sources
Year:
Not specified
Region / City:
Not specified
Theme:
Mineral Processing, Environmental Sustainability, Flotation Chemistry
Document Type:
PhD Project Description
Institution:
Imperial College London, Shell Global Solutions International B.V.
Author:
Not specified
Target Audience:
PhD candidates, researchers, industry professionals in mineral processing
Period of Application:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Document type:
Reporting checklist
Purpose:
Verification of reporting standards in scientific manuscripts
Subject area:
Scientific research reporting and reproducibility
Related sections:
Statistics and general methods; Reagents; Animal models; Human subjects; Data deposition; Code availability
Intended use:
Manuscript submission and editorial review process
Associated materials:
Material & Methods section of a manuscript
Key reporting elements:
Sample size determination; statistical tests; experimental replication; randomization; blinding; reagent sources; animal model description; ethical compliance; human subject consent; clinical trial registration; data repository accession codes
Referenced guidelines:
ARRIVE guidelines; CONSORT statement; REMARK reporting guidelines
Referenced repositories:
ClinicalTrials.gov; Figshare; Dryad
Associated journal resource:
Guide to Authors
Submission system reference:
Editorial Manager
Required contributor fields:
Corresponding author name; manuscript number
Primary research contexts covered:
Animal studies; human subject research; laboratory experiments; computational analysis
Note:
Year
Subject:
Environmental Assessment
Document Type:
Report
Organization:
Indiana Department of Transportation (INDOT)
Author:
Environmental Services Division (ESD)
Target Audience:
Environmental professionals, contractors
Period of Effectiveness:
Not specified
Approval Date:
Not specified
Modification Date:
Not specified
Year:
2023
Region / City:
New York State
Theme:
Cultural Resource Management
Document Type:
Template for Historic Preservation Finding Document
Agency / Institution:
New York State Department of Transportation (NYSDOT)
Author:
Not specified
Target Audience:
Project managers, cultural resource coordinators, historical preservation professionals
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2023
Region / City:
Humber and North Yorkshire
Theme:
Medicine prescribing, healthcare guidelines
Document Type:
Guideline, formulary
Organization / Institution:
Humber and North Yorkshire Area Prescribing Committee
Author:
Humber and North Yorkshire Area Prescribing Committee
Target Audience:
Healthcare professionals (pharmacists, doctors, primary and secondary care providers)
Period of Validity:
Ongoing
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2024
Region / City:
Red Bank
Topic:
Background check, Volunteer vetting
Document Type:
Form
Organization / Institution:
RBAYF
Author:
Red Bank AYF
Target Audience:
Volunteers
Effective Period:
2024
Approval Date:
02/08/2024
Modification Date:
N/A
Year:
2014
Region / City:
Bethesda MD
Topic:
Blood transfusion, red blood cells, medical procedures
Document Type:
Manual
Organization / Institution:
AABB
Author:
MK Fung (Editor)
Target Audience:
Medical professionals, blood transfusion specialists
Period of Validity:
24 hours after preparation
Approval Date:
September 1, 2014
Date of Revision:
April 11, 2016, August 30, 2016
Procedure Code:
CSP.010, IM.002, IM.004
Related Standards:
Canadian Society for Transfusion Medicine, AABB Technical Manual
Keywords:
Washed red blood cells, transfusion, blood processing, medical procedure, IgA deficient patients
Note:
Contextual Description
Year:
2017
Region / City:
Maine
Topic:
Politics, Healthcare, Social Security, Abortion
Document Type:
Political Ad/Press Release
Author:
Unknown
Target Audience:
Voters, Political Constituents, General Public
Period of Validity:
N/A
Approval Date:
N/A
Date of Changes:
N/A
Year:
2022
Region / city:
New Zealand
Topic:
Rugby, COVID-19 Guidelines
Document Type:
Guideline
Organization:
New Zealand Rugby
Author:
New Zealand Rugby
Target Audience:
Rugby clubs, schools, participants, coaches, and managers
Period of Action:
Ongoing, subject to updates based on COVID-19 Protection Framework
Approval Date:
Not specified
Modification Date:
Not specified
Note:
Contextual Description
Year:
Not specified
Organization:
British Red Cross Society
Type of document:
Grant Agreement
Project Name:
Click here to enter text
Project Start Date:
Click here to enter text
Project End Date:
Click here to enter text
Total Grant Amount:
[xxx in grant currency]
Grant Currency:
Click here to enter text
Grant Start Date:
dd/mm/yyyy
Grant End Date:
dd/mm/yyyy
Annexes:
Annex 1 – Receipt of funds form, Annex 2 – Project budget, Annex 3 – Project proposal
Conditions:
Use of funds, Project progress, Reporting requirements, Monitoring and audits, Dispute resolution, Early termination
Note:
Year
Topic:
Cybersecurity, Training
Document Type:
Statement of Work
Agency / Organization:
NAVSEA
Target Audience:
DOD Red Team operators, cybersecurity professionals